{"id":"61291462764-77","name":"SANOFI","registrationDate":"2009-12-11T10:53:11.112+01:00","category":2,"subCategory":3,"legal":"Public limited company","web":"http://www.sanofi.com","country":"France","headAddress":"SANOFI GROUPE","headCity":"Paris","headPostCode":"75008","headPhone":"(33)1 53 77 40 00","boss":"Paul HUDSON","bossTitle":"Mr","bossPosition":"Chief Executive Officer","membersCount":9,"membersFTE":"3.0","membership":"Professional associations:&#xd;\nAESGP - Association of the European Self-Medication Industry&#xd;\nAFEP (French Association of Private Companies) &#xd;\nEBE &#xd;\nEFPIA - European Federation of Pharmaceutical &#xd;\nIndustries Associations - and its specialized groups - EBE and Vaccines Europe &#xd;\nEuropabio&#xd;\nVaccines Europe&#xd;\n&#xd;\nThink tanks :&#xd;\nAECA&#xd;\nBruegel&#xd;\nCercle des délégués permanents&#xd;\nEPC&#xd;\nFriends of Europe &#xd;\nScience Business&#xd;\n&#xd;\nConsulting:&#xd;\nFipra&#xd;\nCRA","memberOrga":"For its 2018 update, Sanofi has decided to use a single entry principle for its registration. Thus, facts and figures include its following entities: Sanofi, Genzyme and Sanofi -Pasteur.","goal":"Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.&#xd;<br />&#xd;<br />With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.&#xd;<br />&#xd;<br />Sanofi, Empowering Life.","acronym":"","interests":"Borders and Security, Business and Industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Employment and Social Affairs, Enlargement, Environment, External Relations, Humanitarian aid and civil protection, Institutional affairs, International co-operation and development, Justice and Fundamental Rights, Public Health, Research and innovation, Single market, Taxation, Trade","euInitiatives":"(alphabetic order) &#xd;<br />Digital in Healthcare, &#xd;<br />EU Competitiveness and Industrial policy, &#xd;<br />EU Research policy / framework program,&#xd;<br />Health Technology Assessment Regulation,&#xd;<br />Falsified Medicines Directive&#xd;<br />Innovative Medicines Initiative (IMI),&#xd;<br />Medical Devices Regulation,&#xd;<br />Paediatric Regulation, &#xd;<br />Pharmaceuticals in the environment,&#xd;<br />Rares diseases Regulation, &#xd;<br />Reach,&#xd;<br />Representative actions for the protection of the collective interests of consumers&#xd;<br />Supplementary protection certificate for medicinal products Regulation&#xd;<br />Trade Agreement,&#xd;<br />Vaccines EU policies","lastUp":"2019-10-31T15:01:31.215+01:00","customers":"","costAbsolu":"","costRange":"1000000-1249999","turnoverAbsolu":0,"turnoverRange":""}